Growth Metrics

Resmed (RMD) Change in Receivables (2016 - 2025)

Resmed's Change in Receivables history spans 17 years, with the latest figure at $72.7 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 7.12% year-over-year to $72.7 million; the TTM value through Dec 2025 reached $88.0 million, down 39.52%, while the annual FY2025 figure was $76.7 million, 42.89% down from the prior year.
  • Change in Receivables reached $72.7 million in Q4 2025 per RMD's latest filing, up from -$30.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $89.3 million in Q2 2021 to a low of -$48.8 million in Q4 2021.
  • Average Change in Receivables over 5 years is $22.5 million, with a median of $20.1 million recorded in 2021.
  • The largest YoY upside for Change in Receivables was 347.27% in 2024 against a maximum downside of 457.35% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$48.8 million in 2021, then surged by 140.16% to $19.6 million in 2022, then soared by 36.85% to $26.8 million in 2023, then surged by 153.15% to $67.9 million in 2024, then increased by 7.12% to $72.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Change in Receivables are $72.7 million (Q4 2025), -$30.0 million (Q3 2025), and $5.2 million (Q2 2025).